Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01524276 · ClinicalTrials.gov registry record
Product Surveillance Registry
A clinical trial of Intracranial Aneurysm and Neurological Disorders, sponsored by Medtronic.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 20
- Study locations
NCT01524276 is a study of Intracranial Aneurysm and Neurological Disorders that is actively recruiting participants, run by Medtronic. The registered enrollment target is 100,000 participants, above the 2,053-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (4771% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT01524276, a study of Intracranial Aneurysm and Neurological Disorders, is actively recruiting participants, sponsored by Medtronic.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Conditions Studied
Study Locations (20)
California
- - Aliso Viejo
- - Chula Vista
- - Colton
- - La Jolla
- - Los Angeles
- - Napa
- - Redwood City
- - Salinas
- - San Diego
- - Stanford
- - Torrance
- - Ventura
Colorado
- - Aurora
- - Colorado Springs
- - Lakewood
Alabama
- - Birmingham
- - Huntsville
Arizona
- - Chandler
- - Phoenix
Arkansas
- - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2012-01 |
| Est. Completion | 2040-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01524276
The ClinicalTrials.gov registry entry for NCT01524276 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,053-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (4771% higher). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Intracranial Aneurysm appearing as the primary indexed condition, and to 0 interventions.
NCT01524276 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, Alabama.
Frequently Asked Questions
What is clinical trial NCT01524276 about?
NCT01524276 is a clinical study titled "Product Surveillance Registry". The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by stre...
What is the current status of trial NCT01524276?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2012-01. Estimated completion is 2040-01.
What conditions does trial NCT01524276 study?
This clinical trial studies the following conditions: Intracranial Aneurysm, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Mechanical Circulatory Support.
Who is sponsoring clinical trial NCT01524276?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01524276 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.